(Q27640324)

https://api.crossref.org/works/10.1074%2FJBC.M212930200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

A model for the mechanism of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Nonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

8-Oxoguanine rearranges the active site of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Acute myelogenous leukemia: current treatment and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

DNA damage in ultraviolet-irradiated HeLa and CHO-Kl cells examined by alkaline lysis and hydroxyapatite chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Solution structure of a DNA dodecamer containing the anti-neoplastic agent arabinosylcytosine: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Molecular structure of a DNA decamber containing an anticancer nucleoside arabinosylcytosine: conformational perturbation by arabinosylcytosine in B-DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

A novel suicide substrate for DNA topoisomerases and site-specific recombinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Melanoplus sanguinipes entomopoxvirus DNA topoisomerase: site-specific DNA transesterification and effects of 5'-bridging phosphorothiolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Suicide substrates reveal properties of the homology-dependent steps during integrative recombination of bacteriophage lambda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

DNA contacts by protein domains of the molluscum contagiosum virus type-1B topoisomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Catalytic mechanism of DNA topoisomerase IB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Regulation of site-specific recombination by the C-terminus of lambda integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Reconstitution of human topoisomerase I by fragment complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Assessment of phase accuracy by cross validation: the free R value. Methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

PROCHECK: a program to check the stereochemical quality of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Raster3D: photorealistic molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Topoisomerase I-mediated DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200

Simple statistics for intensity data from twinned specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212930200